AZD-1222 for Covid-19 prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 105 adverse event reports in the FDA FAERS database where AZD-1222 was used for Covid-19 prophylaxis.
Most Reported Side Effects for AZD-1222
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 838 | 35.8% | 2 | 167 |
| Fatigue | 784 | 33.5% | 6 | 172 |
| Pyrexia | 735 | 31.4% | 2 | 141 |
| Pain | 579 | 24.7% | 0 | 127 |
| Covid-19 | 515 | 22.0% | 2 | 122 |
| Arthralgia | 508 | 21.7% | 1 | 120 |
| Nausea | 494 | 21.1% | 1 | 123 |
| Palpitations | 485 | 20.7% | 0 | 103 |
| Dyspnoea | 472 | 20.1% | 8 | 148 |
| Abdominal discomfort | 467 | 19.9% | 0 | 102 |
| Malaise | 467 | 19.9% | 6 | 117 |
| Migraine | 466 | 19.9% | 0 | 96 |
| Off label use | 463 | 19.8% | 4 | 113 |
| Dizziness | 460 | 19.6% | 1 | 112 |
| Tinnitus | 456 | 19.5% | 0 | 87 |
Other Indications for AZD-1222
Covid-19 immunisation (1,166)
Product used for unknown indication (797)
Immunisation (59)
Adverse drug reaction (49)
Covid-19 (21)
Prophylaxis (19)
Other Drugs Used for Covid-19 prophylaxis
CILGAVIMAB\TIXAGEVIMAB (1,105)
COVID-19 VACCINE NOS (583)
TOZINAMERAN (377)
ELASOMERAN (152)
ALCOHOL (136)
AD26.COV2.S (64)
COVID-19 VACCINE (52)
HYDROXYCHLOROQUINE (52)
CASIRIVIMAB\IMDEVIMAB (51)
CX-024414 (50)